Structural Biology in Drug Design

Drug design is an innovative process to asset new medication based on the knowledge of biological target. Drug is most commonly a small molecule that inhibits or activates the function of a biomolecule, which in turn outcomes in a therapeutic benefit to the patient. Drug design commonly but not essentially relies on computational techniques. This type of modelling is often mentioned to as computer-aided drug design. Drug design that depends on the knowledge of the 3D structure of the target is known as structure-based drug design. The main methods available for drug design are structure based drug design and ligand based drug design.

  • Drug targets
  • Computer-aided drug design
  • Ligand-based design
  • Structure-based design
  • Binding site identification
  • Scoring functions

Related Conference of Structural Biology in Drug Design

May 17-18, 2021

11th World Glycobiology Congress

Vienna, Austria
July 26-27, 2021

5th International Conference on Bioscience and Biotechnology

London, Aland Islands
March 15-16, 2021

12th Tissue Repair and Regeneration Congress

Dubai, UAE
July 30-30, 2021

Glycobiology Biochem Conference 2021

London, UK
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic
September 27-28, 2021

25th European Biotechnology Congress

Dublin, Ireland
November 08-09, 2021

23rd Global Biotechnology Congress

Singapore City, Singapore
December 01-02, 2021

18th International Conference on Metabolomics and Proteomics

Frankfurt, Germany
December 03-04, 2021

International Conference on Biotechnology

Singapore, Singapore

Structural Biology in Drug Design Conference Speakers

Recommended Sessions

Related Journals

Are you interested in